We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe

MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry

MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry

Scope

Coding, payment mechanism, reimbursement tariffs, pathway to create or improve reimbursement situation

 

Project-based on-demand work or >95 off-the-shelf syndicated reports

Countries
19 EU
Availability
Mixed
Scope

Seminars on introduction into market access for medical devices and IVD tests, seminars on reimbursement systems in individual countries (>60 reports)

 

Syndicated analytical reports on the topics of HTA, innovation funding, reimbursement of health apps

Countries
19 EU
Availability
Off-the-shelf
Scope

Fact-based approach to determine evidence requirements, based on the prevision reimbursement decisions

Countries
Europe
Availability
On demand
Scope

Subscription service with email alerts about initiated or published health technology assessments of medical devices and in-vitro diagnostic tests from 47 HTA organizations globally

Countries
18 countries globally
Availability
On-demand

Why us?

Analyses from the same vendor for 19 different EU countries
Analyses from the same vendor for 19 different EU countries

Save money and time, get standardized analysis

Pharma approach is put aside
Pharma approach is put aside

Work with a company truly specialized in medical devices and diagnostics

Getting results instantly (reports) or within 4-8 weeks (services)
Getting results instantly (reports) or within 4-8 weeks (services)

Make business decisions quickly

13 out of top-30 companies choose MTRC for reimbursement support
13 out of top-30 companies choose MTRC for reimbursement support

Work with a provider who understands industry’s needs

More than 110 projects accomplished during the last year
More than 110 projects accomplished during the last year

Work with a provider who has experience in your field

Team of 15 specialists in 6 countries
Team of 15 specialists in 6 countries

Work with a provider with a Pan-European capacity

More than 200 internal instructions and protocols
More than 200 internal instructions and protocols

Be sure about quality of the results

To stay up-to-date, we daily monitor developments of reimbursement systems in Europe

Subscribe to our newsletter to get updates every 2nd week

27 Jul 2020
For the last three years, MTRC maintained a be-weekly newsletter with information about reimbursement and market access changes in European countries. From July 2020, we are extending this activity with an introduction of the paid subscription service HTA Alerts. It will include bi-weekly reports about initiated or published HTAs from 47 HTA organizations worldwide. Reports will be customized so that the clients receive notification for only relevant technologies.

05

Aug 2020

In July 2020, two new apps entered the level 1 of the mHealthBelgium validation pyramid. Healthentia is an eClinical platform to record Real World Data, that can be used either in clinical trials or by healthy individuals. Sunrise (class IIa) sleep testing device allows rapid and at home diagnosing respiratory sleep disorders.

04

Aug 2020

The Clinical Coding and Schedule Development (CCSD) group develops and maintains procedural and diagnostics nomenclature for private payers in England. New procedure codes concern planning, insertion, and removal of high/low dose rate radioactive treatment (brachytherapy) into a prostate tumor, open/laparoscopic repair of Spigelian hernia, and others. The codes are introduced with a recommended adoption date being the 1st of August 2020. The document also contains a list of textual changes in codes and unacceptable combinations. There were no changes to the CCSD Schedule of Diagnostic Tests.

03

Aug 2020

In June 2020, santésuisse (the leading organization of Swiss health insurers) and the Swiss Society of Surgeons (FCMH) have submitted a proposal to the Federal Council for the acceptance of 67 lump-sum payment packages for out-patient services. In July 2020, eight more lump-sum payment packages were suggested to the Federal Council. More suggestions are expected in the near future.

31

Jul 2020

In June 2020, the Andalusian Health Technology Assessment Department (AETSA) published an update of the earlier report (2012) on assessment of effectiveness and safety of tumor treating fields (TTF) therapy in glioblastoma.

Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 19 European countries

Analysis

Reimbursement

  • Availability of procedure / reimbursement code
  • Reimbursement mechanism (diagnosis-related group or fee for service)
  • Availability of add-on reimbursement
  • Availability of innovation funding
  • Reimbursement tariffs

National funding

Willingness to pay for technology, based on:

  • Statements from national commissioners (e.g., NHS England)
  • Health Benefit Catalogues (e.g. in Spain, LEA Levels in Italy)
  • National clinical guidance (e.g. NICE in the UK, Haute Autorité de Santé in France, Socialstyrelsen in Sweden)
  • National health technology assessments in connection with reimbursement decisions (e.g. NICE for Technology Appraisal in the UK, Haute Autorité de Santé in France)
  • Specific funding frameworks (e.g., “New method” in Norway)
Strategy

Reimbursement strategy

Pathway to get reimbursement:

  • Overview of drivers and barriers for adoption
  • Overview of key reimbursement and funding pathways (including state-sponsored studies and innovation funding)
  • Detailed presentation of individual pathways (process, stakeholders, requirements, timelines)
  • Action plan

Check our specific propositions for: Med Tech industry, IVD industry, Investors

Our services cover 19 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Switzerland and Turkey

We provide services for major types of medical technologies

Implantable devices

Interventional procedures

Non-in­ter­ven­tional procedures

In-vitro diagnostic tests

Medical aids

Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, endoscopy and more

Confidence in results

We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:

  • Standard Operating Procedures and Work Instructions
  • Access to official coding and DRG manuals, tariff lists and grouping software
  • A team comprised of experienced Clinical Coders with a medical background
  • Quick access to health authorities to address uncertainties
  • Ongoing research program to get insights from payer and provider interviews
  • All reports are reviewed by the CEO before release

Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • 3D conformal radiation therapy
  • Ablation of heart tissue for atrial fibrillation
  • Ambulatory mammography
  • Angioplasty of arteries of lower extremities for peripheral artery disease
  • Arthroscopic interventions on knee
  • Atherectomy for peripheral artery disease
  • Balloon kyphoplasty
  • Balloon sinus dilation for chronic sinusitis
  • Bariatric surgery
  • Biologic and synthetic skin substitutes
  • Bone Conductive Hearing Device
  • Brachytherapy
  • Breast reconstruction
  • Bronchial thermoplasty
  • Capsule endoscopy
  • Cardiac pacemakers
  • Cardiac resynchronization therapy
  • Carotid endarterectomy
  • Caesarean section
  • Cholecystectomy
  • Cochlear implants for hearing loss
  • Combined report for minimally invasive and transcatheter mitral valve repair and replacement procedures for mitral regurgitation
  • Computed tomography in ambulatory settings
  • Coronary artery bypass grafting
  • Coronary imaging and diagnostic procedures
  • Coronary percutaneous revascularization procedures
  • Deep brain stimulation
  • Diagnostic endoscopic procedures on the lower gastrointestinal tract
  • Diagnostic endoscopic procedures on the upper gastrointestinal tract
  • Endoscopic biliary procedures
  • Gastric electrical stimulation for gastroparesis and obesity
  • Health apps
  • Hemodialysis for acute kidney injury
  • Hemodialysis (out-patient session) for chronic kidney failure
  • Hernia repair
  • Hip replacement
  • Hospital and out-patient remote monitoring coding and reimbursement for neurostimulators
  • Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea Syndrome (OSAS)
  • Hysterectomy
  • Embolic Protection Devices during percutaneous cardiac procedures (PCI and TAVI)
  • Endovascular repair (EVAR) of abdominal aortic aneurysm (AAA)
  • Extra-corporeal membrane oxygenation (ECMO) for pulmonary and cardiac failure
  • Image-guided radiotherapy
  • Implantable Cardiac Monitor for Detection of Cardiac Arrhythmia
  • Implantable cardioverter defibrillators (ICDs)
  • Implantable drug infusion systems for chronic pain
  • Inferior Vena Cava Filter
  • Intensity modulated radiotherapy (IMRT)
  • Left atrial appendage occlusion
  • Lung volume reduction for emphysema
  • Magnetic resonance imaging in ambulatory settings
  • Mechanical ventilzation
  • Mechanical thrombectomy for acute ischemic stroke
  • Minimally-invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Minimally-invasive mitral valve repair with creation of artificial chordae tendonae for mitral regurgitation
  • Minimally-invasive replacement of mitral valve for mitral regurgitation
  • Minimally-invasive reshaping of heart geometry for mitral regurgitation
  • Negative Pressure Wound Therapy (NPWT) 
  • Open replacement of heart valves (all valves)
  • Percutaneous ablation procedures for diseases of lung, prostate, kidney, liver and bone
  • Percutaneous procedures for deep vein thrombosis
  • Percutaneous tibial neuromodulation in overactive bladder
  • Percutaneous vertebroplasty
  • Peripheral embolization procedure
  • Peripheral intravascular ultrasound
  • Peritoneal dialysis for chronic kidney failure
  • Proton Therapy
  • Robotic surgery interventions
  • Sacral nerve stimulation
  • Selective internal radiation therapy (SIRT)
  • Spinal cord stimulation
  • Stereotactic body radiation therapy
  • Stereotactic Radiosurgery
  • Surgical and endovascular treatment of brain aneurysm
  • Transcatheter annuloplasty ring for mitral regurgitation
  • Transcatheter aortic valve implantation (TAVI)
  • Transcatheter mitral annuloplasty using implant placed in the coronary sinus for mitral regurgitation
  • Transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation
  • Transcatheter mitral valve repair using mitral annulus plication for mitral regurgitation
  • Transcatheter mitral valve replacement
  • Treatment of varicose veins
  • Use of intra-aortic balloon pump (myocardial infarction and unstable angina, complicated by cardiogenic shock)
  • Vagus nerve stimulation
  • Vascular access for long-term use: AV fistula and AV graft
  • Ventricular assist devices for circulatory support
  • Volumetric modulated arc therapy (VMAT)

Ongoing reports:

  • Companion diagnostic tests for breast cancer
  • Treatment of burns
  • Biologic and synthetic skin substitutes